contact.

company history.

from innovation to impact.

March 2022

Foundation
novaxomx GmbH

Joint venture of curasan AG and Xlife Sciences AG.

March 2022

November 2022

Signed license agreement

novaxomx signs license agreement for the use of the patented exosome technology

November 2022

2023

Start of first
pre-clinical trial

together with the University Hospital Jena

2023

2025

Publication of pre-clinical trial results

together with University Hospital Jena

2025

01/2025

start of pre-clinical in-vivo animal study

with the university hospital Jena

01/2025

feel free to contact us.